WBA not overly worried by rising Amazon threat
This article was originally published in OTC Bulletin & The Rose Sheet
Walgreens Boots Alliance (WBA) is “not particularly worried” by online retail giant Amazon’s growing interest in the pharmacy market, according to the wholesale and retail giant’s chief executive officer Stefano Pessina.
You may also be interested in...
Amazon’s nutrition and wellness sales soared 55% in 2018 to around $2.5bn and health product sales, including OTC drugs, jumped 50% to about $600m, as consumers grow more comfortable purchasing health products online, says e-commerce market research firm Edge by Ascential.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.